NASDAQ
14.05.25 | 15:38
10,330 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Brainsway Inc. Q1 Earnings Summary | - | RTTNews | ||
| Di | BrainsWay GAAP EPS of $0.02 in-line, revenue of $11.54M beats by $0.09M | 1 | Seeking Alpha | ||
| Di | BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights | 114 | GlobeNewswire (Europe) | Achieved record quarterly sales of $11.5 million in Q1 2025, an increase of 27% compared to Q1 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.3 million, increasing by... ► Artikel lesen | |
| Di | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Mo | BrainsWay Q1 2025 Earnings Preview | 1 | Seeking Alpha | ||
| 22.04. | BrainsWay files to sell up to 3.6M American Depositary Shares for holders | 3 | Seeking Alpha | ||
| 11.03. | BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights | 200 | GlobeNewswire (Europe) | Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 million Exceeded full year 2024 operating... ► Artikel lesen | |
| BRAINSWAY Aktie jetzt für 0€ handeln | |||||
| 11.03. | BrainsWay GAAP EPS of $0.04 beats by $0.02, revenue of $11.41M beats by $0.52M | 2 | Seeking Alpha | ||
| 11.03. | Brainsway Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 10.03. | BrainsWay Q4 2024 Earnings Preview | 2 | Seeking Alpha | ||
| 12.12.24 | BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder | 1 | GlobeNewswire (USA) | ||
| 12.12.24 | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.11.24 | BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy | 1 | GlobeNewswire (USA) | ||
| 20.11.24 | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.11.24 | BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights | 178 | GlobeNewswire (Europe) | Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET BURLINGTON... ► Artikel lesen | |
| 29.08.24 | BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer | 140 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments... ► Artikel lesen | |
| 06.08.24 | BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights | 186 | GlobeNewswire (Europe) | Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024 Recorded Positive Quarterly Net Income for Third Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations for Fourth... ► Artikel lesen | |
| 03.06.24 | BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression | 167 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, June 03, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 48,440 | +0,60 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 62,00 | +0,16 % | Ihre wichtigsten Termine: Alle Blicke auf: Boeing, Bayer, Carl Zeiss Meditec, Rheinmetall, Sixt & Jenoptik | © Foto: Bayer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen | |
| ECKERT & ZIEGLER | 61,45 | -1,60 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
| UNITEDHEALTH | 228,60 | -17,11 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| TELADOC HEALTH | 6,288 | -4,39 % | Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now | ||
| HIMS & HERS HEALTH | 52,84 | -3,51 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| ALCON | 78,48 | -0,25 % | Dividendenbekanntmachungen (13.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALCON AG CH0432492467 0,28 CHF 0,2984 EUR ALGOMA STEEL GROUP INC CA0156581070 0,05 USD 0,045 EUR ALSEA SAB DE CV MXP001391012 1... ► Artikel lesen | |
| RESMED | 221,90 | +0,36 % | Dividendenbekanntmachungen (08.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDNODE GROUP AB SE0017885767 1,15 SEK 0,1052 EUR AG BARR PLC GB00B6XZKY75 0,1376 GBP 0,1617 EUR ALANTRA PARTNERS SA ES0126501131 - 0... ► Artikel lesen | |
| AMBU | 13,800 | -1,43 % | UBS initiates Ambu stock with buy rating, DKK147 target | ||
| LIFEWARD | 1,370 | -4,86 % | Lifeward Ltd. Reports First Quarter 2025 Financial Results | U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved... ► Artikel lesen | |
| BONESUPPORT | 26,060 | +0,62 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
| ICON | 117,00 | -1,22 % | ICON plc: Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies | ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across... ► Artikel lesen | |
| TELEFLEX | 111,00 | -1,77 % | Teleflex Incorporated: Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting | ||
| DELCATH SYSTEMS | 13,500 | -2,88 % | Delcath Systems targets 30 active centers by year-end 2025 amid strong Q1 performance | ||
| INSPIRE MEDICAL SYSTEMS | 136,45 | -2,29 % | Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook | Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire... ► Artikel lesen |
Das Unternehmen BRAINSWAY LTD ADR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 10,330 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAINSWAY LTD ADR finden Sie auf Wallstreet Online.